Traws Pharma, Inc. — Director's Dealing 2013

Aug 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-07-30

Reporting Person: Altland James (SVP, Finance & Corp. Develop.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-07-30	Common Stock	M	5000	$6.00	Acquired	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-07-30	Stock Option (right to purchase)	$6.00	M	5000	Disposed	2017-08-01	Common Stock (5000)	Direct